Tag:

Facebook

Latest Headlines

Latest Headlines

Facebook mulls move into healthcare sector

Reuters reports that Facebook is considering setting up patient support communities and has met with people in the medical industry to discuss its plans.

Facebook, Twitter and YouTube targeted in fake drug crackdown

Authorities removed more than 19,000 ads on Facebook, Twitter and YouTube that promoted the illegal sale of medicines.

Facebook now gets 59% of ad revenue from mobile

Facebook saw a surge in mobile advertising revenue in the first quarter and the social network said it now counts more than 1 billion mobile monthly active users.

Tufts survey shows social media still on fringes of clinical trials

It is almost four years since Facebook passed 500 million users. And while the role of it and other social media in clinical trials has generated lots of media coverage and conference chatter, the industry is yet to fully embrace the tools. Survey data published this week show just how there is to go.

For once, the FDA writes up pharma for a simple Facebook violation

The FDA has slapped another drugmaker on Facebook. And this time, the agency's complaints don't raise thorny questions or create new gray areas. The untitled letter to Institut Biochimique and its U.S. partner Akrimax Pharmaceuticals is about as garden-variety as they come.

The top 10 pharma companies in social media

Chatting with the public is not in pharma's comfort zone. Drugmakers are adept at the one-way communication known as direct-to-consumer advertising, and some of them deal well with the media....

FDA: The social media guidance puzzle will be complete by July

Forget a unified theory of social media from the FDA. It's going to be more of a puzzle-piece approach. As  Regulatory Focus  reports, the FDA plans to issue several more sets of rules for pharma companies using Twitter, Facebook, Pinterest, et al.  

Scientists increasingly receptive to life science vendors on social media

Life science vendors face a balancing act when using social media. Giving users the hard sell will bring rejection and reflect badly on the company, but a softly-softly plan might not be noticed at all. Fortunately for vendors, a survey suggests scientists are increasingly accepting of companies on Facebook and Twitter.

Novartis leverages Facebook to personalize eye health campaign

The project pulls in pictures from a user's Facebook account to personalize a video that simulates the effect of vision loss.

Broker's Facebook rant on biotech stock draws $5K fine

A stockbroker who took to his Facebook page to sound off in reaction to a critical online report last year regarding Arena Pharmaceuticals has been fined $5,000 for the outburst via social media.